Not recruiting
Respiratory syncytial virus infection
Not recruitingStudy on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease
Registered drugNo placebo
Study on the Safety and Immune Response of RSVPreF3 OA Vaccine with PCV20 in Adults Aged 60 and Older with RSV Disease
Registered drugNo placebo
- Disease:Respiratory syncytial virus infection
- Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium PhosphatePneumococcal Polysaccharide Serotype 10A Conjugated To Crm197 Adsorbed On Aluminium Phosphate+18
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years · Healthy volunteers
- Substances:Pneumococcal Polysaccharide Serotype 1 Conjugated To Crm197 Adsorbed On Aluminium Phosphate
